InsidersTradesSigma
Browse the complete record of transactions filed by Holsinger Leslie, Directeur Exécutif. Officer active across 1 companies, notably Cortexyme, Inc.. In total, 2 disclosures have been recorded. The latest transaction was disclosed on 6 June 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Leslie Holsinger is Executive Vice President and head of preclinical development at Cortexyme, Inc. In this role, she oversees research and development initiatives, ensuring that projects progress efficiently. Her expertise is crucial for the success of the company's research efforts.